Loading viewer...
earnings
Format: PDF earnings
Gilead Sciences presents third quarter 2022 financial and operational results, including commercial performance across virology, oncology and other programs. The presentation discusses progress on key product candidates, clinical trial updates, and the impact of COVID-19 and Veklury on business operations.
earnings
59 Pages
earnings
19 Pages
QuidelOrtho
Yara International 2023 Q4 Results February 2024
earningsearnings
34 Pages
Yara International ASA
Hong Leong Financial Group 1H FY24 Earnings Results Presentation
earningsearnings
24 Pages
Hong Leong Financial Group Berhad
CEMEX 2016 Q2 Earnings Results
earningsearnings
32 Pages
Cemex S.A.B. de C.V